comparemela.com
Home
Live Updates
Much-Improved Outcomes for Follicular Lymphoma Transformed t
Much-Improved Outcomes for Follicular Lymphoma Transformed t
Much-Improved Outcomes for Follicular Lymphoma Transformed to DLBCL in the Rituximab Era, Study Finds
Although histological transformation to diffuse large B-cell lymphoma (DLBCL) remains a common complication of follicular lymphoma, patient survival has increased significantly since the introduction of rituximab about 2 decades ago.
Related Keywords
,
Genentech ,
Image Credit ,
Cancer Medicine ,
End Results ,
Dlbcl ,
Follicular Lymphoma ,
Rituximab ,